NFKB1 and cancer: In several cancer types, NF-κB is constitutively activated, resulting in unregulated proliferation, thus making it an important therapeutic target in many cancers such as breast cancer, lung cancer, gastric and colorectal cancer as well as hematologic malignancies [2,6,7,8,9,10,11].